Back to 
Hood River Capital Management LLC
Hood River Capital Management LLC
PTGX2 quarters
Position history for Hood River Capital Management LLC's holdings in PROTAGONIST THERAPEUTICS INC
Yes. Hood River Capital Management holds 882,738 shares of PTGX (Protagonist Therapeutics), worth $108.2M, as of its Q2 2026 13F filing. It increased the position by 53,453 shares (+6.5%) from Q1 2026. Hood River Capital Management has held PTGX since Q1 2026, across 2 quarterly 13F filings. PTGX is 0.8% of Hood River Capital Management's reported 13F portfolio.
Current Value
$108.2M
Current Shares
882,738
Total Value Change
+$20.8M
Total Shares Change
+53,453
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.